Prenetics Global Limited (PRE) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Prenetics Global Limited (PRE:NASDAQ), powered by AI.

Current Price
$21.63
Sector
Healthcare
What is the Prenetics Global Limited stock price forecast?

Prenetics Global Limited is currently trading at $21.63. View real-time AI analysis on Alpha Lenz.

What is Prenetics Global Limited insider trading activity?

View the latest insider trading data for Prenetics Global Limited on Alpha Lenz.

What is Prenetics Global Limited's P/E ratio?

View Prenetics Global Limited's valuation metrics on Alpha Lenz.

Prenetics Global Limited

NASDAQ · PRE
$21.63+0.94(+4.54%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Prenetics Global Limited's future dividend policy...
Alpha Chat Insight

Prenetics Global Limited's ROE is -23.1%. Explore profitability and growth together.

Ask for details

Company Overview

Prenetics Global Limited is a biotechnology company specializing in genetic and diagnostic testing services. It plays a pivotal role in the healthcare sector by utilizing advanced technology to offer a variety of solutions aimed at improving and personalizing patient care. Prenetics provides genetic testing that helps individuals understand their predisposition to certain health conditions, enabling proactive healthcare decisions. Additionally, their diagnostic services, such as rapidly accessible COVID-19 testing kits, have been critical during health crises, showcasing the company's ability to swiftly meet public health needs. By bridging technology and medicine, Prenetics impacts industries spanning healthcare, biotechnology, and consumer health products. With headquarters in Hong Kong and a global reach, it underscores the importance of precision medicine in modern healthcare, catering to both individuals and businesses seeking reliable and accurate health data. Through innovation and strategic partnerships, Prenetics fortifies its position as a key player in the genetic testing and diagnostics fields, significantly influencing the way health data is collected, analyzed, and applied.

CEOMr. Sheng Wu Yeung
SectorHealthcare
IndustryDiagnostics & Research
Employees285

Company Statistics

FY 2025

Profile

N/AMarket Cap
$92.39MRevenue
0.00Shares Out
285Employees

Margins

52.81%Gross
-37.30%EBITDA
-41.27%Operating
-39.20%Pre-Tax
-43.27%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

91.46%Rev 3Yr
7.23%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-19.05%ROA
-23.07%ROE
-17.14%ROIC

Financial Health

$32.13MCash & Cash Equivalents
$17.58MNet Debt
31.79%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Prenetics Global Limited (ticker: PRE) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 285 employees.

The current price is $21.63 with a P/E ratio of -x and P/B of -x.

ROE is -23.07% and operating margin is -41.27%. Annual revenue is $92M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Prenetics Global Limited (PRE) Stock Forecast 2026 $21.63 — Price, Financials & Analyst Targets | Alpha Lenz